Today's essay says the disguise that got you through training — never look stupid — is the thing that stops you from building. Here's what shipping-while-a-beginner looks like at national scale: every year, roughly 500 organizations clear their first-ever FDA 510(k) medical device. In 2024, 43% of all companies that cleared a device had never cleared one before. The beginner tax is real and measurable — about a month of extra review time — and they pay it, and then they're veterans. Hover any year. Toggle to the share view. Watch fifty years of first attempts.
25,351 organizations. Every one started with a first filing.
Since the 510(k) program began in 1976, 25,351 distinct organizations have cleared at least one medical device through it. None of them were grandfathered in as experts. Each one, at some point, submitted a first application to a federal regulator — the institutional version of posting the half-finished thing in the public channel.
25,351
organizations with ≥1 clearance since 1976
~528/yr
first-time applicants clearing, 2015–2024 avg
43%
of 2024's clearing companies were first-timers
+32 days
the beginner tax — extra median review, 2020s
The chart
First-timers never stopped coming
Red bars: organizations clearing their first-ever 510(k) that year. Navy line: total devices cleared. The industry consolidated, the rules hardened, software ate the device world — and the red bars barely moved. Toggle to share view for the sharper claim: for fifty years, roughly four in ten companies clearing devices in any given year were doing it for the first time.
first-time applicantstotal clearances
Hover a year for the full readout. 1976 is a window artifact — the program's first year makes every applicant a "first-timer" by construction. 2026 (partial year, through Jul 2) excluded.
The beginner tax, by decade · median FDA review days for a cleared device
Through the 1990s, first-timers cleared as fast as veterans — the 1970s ones were actually faster. The gap is a modern invention: +16 days in the 2000s, +27 in the 2010s, +32 in the 2020s. That's the entire measurable cost of being new: about a month.
Read it like the essay does: the barrier to shipping a regulated medical device was never "being a veteran" — 43% of last year's clearing companies weren't. The tax on inexperience is ~32 days of review, not a rejection. The expensive thing isn't looking like a beginner to the FDA. It's the years spent not filing.
Critical lens
What "first-timer" can and can't mean here
Names, not entities. Applicants are matched by company name (uppercased, trimmed). Renames, subsidiaries, and acquisitions split one real organization into several "first-timers" — and a first filing by a spun-out division of Medtronic is not a garage startup. Treat the red bars as an upper-bound census of new names, not new companies.
510(k) is the "substantially equivalent" lane. These clearances ride on a predicate device; novel, higher-risk devices go through PMA or De Novo, which are far harder and rarer. And a clearance is a regulatory event, not proof anyone adopted, bought, or benefited from the device. Shipping ≠ succeeding — the essay's point survives that honesty; the chart's triumphalism shouldn't exceed it.
The review-time gap has confounders. First-timers may file different kinds of devices (more software, more novel product codes) than veterans, so the +32 days isn't a clean "inexperience penalty" — it's the all-in observed difference. Cleared-only data also hides first-timers who filed and never cleared; survivorship bias flatters the beginners you can see.
The 80/20 read: a federal regulator processes ~500 institutional acts of looking-stupid a year, prices the inexperience at roughly a month, and clears the device anyway. Your version — the ugly prototype, the dumb FHIR question, the email to IT — has a lower tax and no submission fee. The system that feels like it punishes beginners mostly just meters them.